Peapack Gladstone Financial Corp bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,357 shares of the company’s stock, valued at approximately $226,000.
Several other institutional investors have also modified their holdings of HQY. Wealthfront Advisers LLC acquired a new position in shares of HealthEquity during the 4th quarter worth approximately $10,304,089,000. Norges Bank acquired a new stake in shares of HealthEquity in the fourth quarter valued at about $74,701,000. Raymond James Financial Inc. acquired a new stake in HealthEquity during the fourth quarter worth approximately $45,728,000. Artisan Partners Limited Partnership acquired a new stake in HealthEquity during the fourth quarter worth approximately $24,568,000. Finally, Geneva Capital Management LLC boosted its holdings in HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after acquiring an additional 206,894 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.
Wall Street Analysts Forecast Growth
HQY has been the topic of a number of recent research reports. Barrington Research restated an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, March 14th. KeyCorp cut their price objective on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Monday, March 24th. Wells Fargo & Company increased their target price on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, The Goldman Sachs Group reduced their price objective on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research report on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $112.58.
HealthEquity Stock Up 8.3 %
HQY stock opened at $83.13 on Thursday. The company has a market cap of $7.19 billion, a price-to-earnings ratio of 76.27, a PEG ratio of 1.60 and a beta of 0.49. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The firm has a 50-day moving average of $98.83 and a two-hundred day moving average of $96.26.
Insider Transactions at HealthEquity
In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Stories
- Five stocks we like better than HealthEquity
- Upcoming IPO Stock Lockup Period, Explained
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Are Tariffs Threatening Disney’s Comeback Story?
- NYSE Stocks Give Investors a Variety of Quality Options
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.